Protara Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Protara Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2013 to Q3 2024.
  • Protara Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 20.6M shares, a 81.5% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 20.6M +9.26M +81.5% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 20.6M +9.32M +82.4% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 11.4M +127K +1.12% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 11.4M +97.5K +0.87% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 11.4M +97.5K +0.87% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 11.3M +50.8K +0.45% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 11.3M +54.8K +0.49% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 11.3M +31.7K +0.28% Dec 31, 2022 10-K 2024-03-13
Q3 2022 11.3M +31.7K +0.28% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 11.3M +23.3K +0.21% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 11.3M +23.3K +0.21% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 11.2M +23.9K +0.21% Dec 31, 2021 10-K 2023-03-08
Q3 2021 11.2M +714K +6.79% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 11.2M +5.39M +92.3% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 11.2M +5.39M +92.2% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 11.2M +8.58M +327% Dec 31, 2020 10-K 2022-03-09
Q3 2020 10.5M -9.06M -46.3% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 5.84M -13.7M -70.2% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 5.84M -13.7M -70.2% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 2.63M +2.15M +446% Dec 31, 2019 10-K 2021-03-11
Q3 2019 19.6M +364K +1.89% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 19.6M +1.86M +10.5% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 19.6M +1.91M +10.8% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 481K -17.2M -97.3% Dec 31, 2018 10-K 2020-03-20
Q3 2018 19.2M +1.6M +9.09% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 17.7M +107K +0.61% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 17.7M +904K +5.39% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 17.7M +1.07M +6.45% Dec 31, 2017 10-K 2019-03-13
Q3 2017 17.6M +1.04M +6.25% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 17.6M +1.04M +6.3% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 16.8M +263K +1.59% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 16.6M +102K +0.62% Dec 31, 2016 10-K 2018-03-14
Q3 2016 16.6M +103K +0.63% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 16.6M +116K +0.71% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 16.5M +59.2K +0.36% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 16.5M +53K +0.32% Dec 31, 2015 10-K 2017-03-16
Q3 2015 16.5M +16.2M +6749% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 16.5M Jun 30, 2015 10-Q 2015-08-13
Q1 2015 16.4M Mar 31, 2015 10-Q 2015-05-13
Q4 2014 16.4M +16.2M +6756% Dec 31, 2014 10-K 2016-03-14
Q3 2014 241K Sep 30, 2014 10-Q 2014-11-25
Q4 2013 240K Dec 31, 2013 10-K 2015-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.